INNOVUS PHARMACEUTICALS, INC.
company.status.inactiveCIK 1411879fmd_015WQ3K74QPB355Q6BBX223RZSManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2009 to Sep 30, 2019, 39 periods
| Line item | FY2009 | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | – | – | 0 | 0 | 0 | 1 | 1 | 5 | 9 | 24 |
| Cost of revenue | – | – | – | 0 | 0 | 0 | 0 | 1 | 2 | 4 |
| Gross profit | – | – | – | 0 | 0 | 1 | 0 | 4 | 7 | 20 |
| Research and development | – | – | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling, general and administrative | – | – | – | – | – | – | 4 | 9 | 12 | 25 |
| Total operating expenses | – | 0 | 2 | 0 | 4 | 5 | 5 | 11 | 14 | – |
| Operating income | – | – | – | (0) | (4) | (4) | (4) | (6) | (5) | (6) |
| Interest expense | – | (0) | 0 | 0 | 0 | 1 | 1 | 7 | 1 | 1 |
| Other non-operating income (expense) | – | – | – | – | – | (1) | (1) | (8) | (1) | (3) |
| Income before taxes | – | (0) | (2) | (0) | – | (5) | (5) | (14) | (7) | (8) |
| Income tax expense | – | – | 0 | 0 | – | – | (1) | 0 | 0 | – |
| Net income from continuing operations | – | (0) | (2) | (0) | (4) | (4) | (4) | (14) | (7) | – |
| Net income | (0) | (0) | (2) | (0) | (4) | (5) | (4) | (14) | (7) | (8) |